Hematology & Oncology Doctors in Jefferson City, MO Accepting Medicare

7 Hematology & Oncology doctors found. Showing 1 - 7

Rolando Daniel Breier, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-893-6404    Fax: 573-893-6505

Shadi Maher Haddadin, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-556-7718

Dr. Tamara Vann Hopkins, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1241 W. Stadium Blvd., Jefferson City, MO 65109 Phone: 573-556-7718    Fax: 573-556-1701

Joseph J Doggett, D.O. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1432 Southwest Boulevard, Jefferson City, MO 65109 Phone: 573-632-5482    Fax: 573-632-5874

Dr. John Savooji, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1432 Southwest Blvd, Jefferson City, MO 65109 Phone: 573-632-4800    Fax: 573-632-4890

Dr. David Douglas Westhoff, MD,PHD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3605 Missouri Blvd, Jefferson City, MO 65109 Phone: 573-526-1104

Dr. Ali Khojasteh, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-893-6404    Fax: 573-893-6505

News Archive

Labopharm intends to draw down $1 million on SEDA; issues discount shares to YA Global Master

Labopharm Inc. today announced it has provided YA Global Master SPV Ltd. with notice of its intention to draw down $1 million under its previously announced standby equity distribution agreement (SEDA). (All currency figures are in Canadian dollars.)

Rats sniff each other to signal a social hierarchy and prevent aggressive behavior

Sniffing, a common behavior in dogs, cats and other animals, has been observed to also serve as a method for rats to communicate-a fundamental discovery that may help scientists identify brain regions critical for interpreting communications cues and what brain malfunctions may cause some complex social disorders.

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

Today's Food and Drug Administration approval of the first CAR T-cell therapy for mantle cell lymphoma represents a key advance for patients with relapsed or treatment-resistant forms of the disease, say Dana-Farber Cancer Institute investigators who helped conduct the decisive clinical trial of the therapy.

NCI awards Provocative Questions grant to Mount Sinai School of Medicine researchers

Two Mount Sinai School of Medicine researchers are among a select group of scientists from around the world who have been recognized by the National Cancer Institute (NCI) for their quest to answer the most pressing questions about cancer. Stuart Aaronson, MD, Professor and Chair of Oncological Sciences and Ross Cagan, PhD, Professor of Oncological Sciences at Mount Sinai, have received the NCI's new "Provocative Questions" grant, which was established to explore the important yet less obvious questions about cancer that may have been neglected in this era of significant discovery.

Read more Medical News

› Verified 5 days ago